scholarly journals Cutaneous Necrosis after Subcutaneous Injection of Polyethylene-Glycol-modified Interferon alpha

2002 ◽  
Vol 82 (4) ◽  
pp. 310-312 ◽  
Author(s):  
Hjalmar Kurzen ◽  
Wolfgang Hartschuh ◽  
Uta Jappe ◽  
Detlef Petzoldt
2010 ◽  
Vol 2010 ◽  
pp. 1-4 ◽  
Author(s):  
Robert M. Friedman ◽  
Sara Contente

Interferons were first described in 1957, but it was not until 34 years after their discovery that sufficient quantities of it were available for treatment of hepatitis C virus (HCV) infections, Clinicians now have an excellent understanding of the basis for the effectiveness of interferon alpha (IFN-) in the therapy of this disease. Treatment with IFN- is more efficient when it complemented by the antiviral ribavirin and the IFN- is conjugated with polyethylene glycol to form peginterferon. In the near future treatment of HCV with IFN- may involve new anti-HCV agents that are currently under development.


1970 ◽  
Vol 17 (2) ◽  
pp. 113-116 ◽  
Author(s):  
MA Ahad ◽  
MA Alim ◽  
ARM Saifuddin Ekram

The interferons (IFNs) are group of naturally occurring cytokines that are secreted by cells of mammalian immune system when they are stimulated by viral, bacterial and other antigens. There are number of alpha IFNs available for treatment purposes. The two most commonly used α-2a and α-2b are made by recombinant technology. When interferon Alpha-2a is combined with polyethylene glycol (PEG), it is known as pegylated interferon or PEG interferon. Polyethylene glycol (PEG) is a safe, inert and nontoxic molecule. Therapeutic benefits of altering proteins with PEG include an improvement in half-life due to reduced renal and cellular clearance, enhanced protection from proteolysis and a reduction in toxicity.   doi: 10.3329/taj.v17i2.3460   TAJ 2004; 17(2): 113-116


2005 ◽  
Vol 53 (1) ◽  
pp. 62-66 ◽  
Author(s):  
Joan Dalmau ◽  
Carmen Lucia Pimentel ◽  
Luis Puig ◽  
Laura Peramiquel ◽  
Esther Roé ◽  
...  

2017 ◽  
Vol 40 (1) ◽  
pp. 35-42
Author(s):  
Weidong Zhou ◽  
Daru Lu ◽  
Xiaojin Liao ◽  
Lu Zhuang ◽  
Li Sun

1996 ◽  
Vol 25 (2) ◽  
pp. 271 ◽  
Author(s):  
G. Kontochristopoulos ◽  
C. Stavrinos ◽  
K. Aroni ◽  
N.C. Tassopoulos

2021 ◽  
Vol 8 (1) ◽  
pp. 12-14
Author(s):  
J Robinson ◽  
I Banerjee ◽  
B Roy ◽  
A Leclézio

Background: Pegylated Interferon Alpha-2b is synthesized via the use of PEG (polyethylene glycol). It is formulated via attaching a 12kDa mono methoxy polyethylene glycol moiety to the recombinant human Interferon Alpha-2b protein. Pegylated Interferon Alpha-2b acts via binding to the (JAK/STAT) Janus kinase signal transducer and activator of the transcription interferon receptor. The Pegylated Interferon Alpha-2b /Virafin binds to the (IFNAR1/2) alpha interferon receptor 1 and 2. Pegylated Interferon Alpha-2b better known as Virafin has been approved by the Drugs Controller General of India. This therapeutic agent is currently under a multicentric phase 3 trial with very promising results being reported. A single subcutaneous dose of Virafin has been shown to decrease the need for oxygen therapy in patients. This reduction in the need for oxygen therapy is a vital factor needed to provide relief to the Indian medical system in light of the recent oxygen shortages faced due to India’s worst wave of COVID-19 cases since the onset of the global pandemic. Pegylated Interferon Alpha-2b/ Virafin confers enhanced viral clearance and bolsters the immune response to induce a quicker recovery in patients with mild to moderate symptoms. Conclusion: It is of paramount importance that further research on Virafin is undertaken as it can hinder the progression of COVID-19, reduce pressure on the inundated health systems, and save countless lives.


2009 ◽  
Vol 21 (1) ◽  
pp. 243
Author(s):  
S. H. Choi ◽  
K. H. Cho ◽  
Y. S. Park

Superovulation in bovine is usually achieved after several FSH injection in a time-consuming protocol, and the half-life of FSH is very short. This study was carried out to assess the efficiency of embryo production after induction of superovulation with a single injection of FSH (Folltropin-V, Vetrepharm, Canada) dissolved in polyethylene glycol (PEG, 8000 MW, Sigma-Aldrich Corp., St. Louis, MO, USA) in Korean Native cows. Eighty-eight cows were randomly assigned to one of four groups. In Group 1 (control), cows were intramuscularly treated with twice-daily administration of 50 mg FSH for 4 days. In Group 2 and 3, cows received a single subcutaneous injection of 400 mg and 200 mg FSH dissolved in 30% PEG, respectively. In Group 4, cows received a single subcutaneous injection of 200 mg FSH dissolved in 30% PEG given seven days after CIDR insertion. On days 10 to 12 after observed estrus, superovulation was started. Luteolysis was induced by administration of 25 mg of PGF2α (Pharmacia, Puurs, Belgium) IM 2 days after the start of the FSH injection. Donors were timed-inseminated with frozen–thawed semen at 48 and 60 h after the administration of PGF2α. Embryos were collected by non-surgical methods on 7 days after the second AI. The numbers of corpus lutea (CL), total ova, transferable embryos, and progesterone concentration were analyzed by General Linear Models Procedure with the Statistical Analysis System (SAS; SAS Institute, Inc., Cary, NC, USA) and means were compared with the Duncan’s multiple range test. Data on the pregnancy rate was analyzed by chi-square test. P values <0.05 were considered to be significantly different. The number of CL in Group 2 was significantly (P < 0.05) higher compared to Groups 1, 3 and 4 (18.5 ± 7.5 v. 11.2 ± 5.1, 13.1 ± 5.1 and 13.9 ± 6.4, respectively). However, the number of total ova (7.9 ± 6.0 to 10.4 ± 7.2) and transferable embryos (3.7 ± 3.3 to 4.7 ± 3.9) did not differ among treatment groups. In addition, blood progesterone concentrations at embryo recovery did not differ among all groups (10.0 ± 3.5 ng mL–1 to 15.7 ± 3.2 ng mL–1). No difference was observed among groups in pregnancy rate after transferring the recovered embryos (36.0 to 50.0%). In conclusion, our results show that a single injection of FSH dissolved in polyethylene glycol is an efficient and simple procedure for inducing superovulation in Korean native cows.


Sign in / Sign up

Export Citation Format

Share Document